SEARCH

SEARCH BY CITATION

References

  • 1
    Partinen M, Hublin C. Epidemiology of sleep disorders. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia: Elsevier Saunders, 2005. p 626-647.
  • 2
    Sherlock S, Summerskill WH, White LP, Phear EA. Portal-systemic encephalopathy; neurological complications of liver disease. Lancet 1954;267:454-457.
  • 3
    Wiltfang J, Nolte W, von Heppe J, Bahn E, Pilz J, Hajak G, et al. Sleep disorders and portal-systemic encephalopathy following transjugular intrahepatic portosystemic stent shunt in patients with liver cirrhosis. Relation to plasma tryptophan. Adv Exp Med Biol 1999;467:169-176.
  • 4
    Bergonzi P, Bianco A, Mazza S, Mennuni G, Zolo P. [Organization of nocturnal sleep in patients with liver cirrhosis: changes before and after treatment with levodopa and lactulose.] Riv Neurol 1975;45:118-123.
  • 5
    Cordoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology 1998;27:339-345.
  • 6
    Bianchi G, Marchesini G, Nicolino F, Graziani R, Sgarbi D, Loguercio C, et al. Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis 2005;37:593-600.
  • 7
    Montagnese S, Middleton B, Skene DJ, Morgan MY. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis. Liver Int 2009;29:1372-1382.
  • 8
    Mostacci B, Ferlisi M, Baldi AA, Sama C, Morelli C, Mondini S, et al. Sleep disturbance and daytime sleepiness in patients with cirrhosis: a case control study. Neurol Sci 2008;29:237-240.
  • 9
    Montagnese S, Middleton B, Mani AR, Skene DJ, Morgan MY. Sleep and circadian abnormalities in patients with cirrhosis: features of delayed sleep phase syndrome? Metab Brain Dis 2009;24:427-439.
  • 10
    Spahr L, Coeytaux A, Giostra E, Hadengue A, Annoni JM. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial. Am J Gastroenterol 2007;102:744-753.
    Direct Link:
  • 11
    Cordoba J, Dupuis J, Gottstein J, Blei AT. Stenosis of a portacaval anastomosis affects circadian locomotor activity in the rat: a multivariable analysis. Am J Physiol 1997;273:G1218-G1225.
  • 12
    Llansola M, Cantero JL, Hita-Yanez E, Mirones-Maldonado MJ, Piedrafita B, Ahabrach H, et al. Progressive reduction of sleep time and quality in rats with hepatic encephalopathy caused by portacaval shunts. Neuroscience 2012;201:199-208.
  • 13
    Coy DL, Mehta R, Zee P, Salchli F, Turek FW, Blei AT. Portal-systemic shunting and the disruption of circadian locomotor activity in the rat. Gastroenterology 1992;103:222-228.
  • 14
    Kantermann T, Juda M, Merrow M, Roenneberg T. The human circadian clock's seasonal adjustment is disrupted by daylight saving time. Curr Biol 2007;17:1996-2000.
  • 15
    Filipski E, Subramanian P, Carriere J, Guettier C, Barbason H, Levi F. Circadian disruption accelerates liver carcinogenesis in mice. Mutat Res 2009;680:95-105.
  • 16
    Samanta J, Dhiman RK, Khatri A, Thumburu KK, Grover S, Duseja A, et al. Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis. Metab Brain Dis 2013;28:249-259.
  • 17
    De Rui M, Schiff S, Aprile D, Angeli P, Bombonato G, Bolognesi M, et al. Excessive daytime sleepiness and hepatic encephalopathy: it is worth asking. Metab Brain Dis 2013;28:245-248.
  • 18
    Bersagliere A, Raduazzo ID, Nardi M, Schiff S, Gatta A, Amodio P, et al. Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis. Hepatology 2012;55:869-878.
  • 19
    Bersagliere A, Raduazzo ID, Schiff S, Gatta A, Merkel C, Amodio P, et al. Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis. Clin Neurophysiol 2013;124:492-496.
  • 20
    Bajaj JS, Saeian K, Schubert CM, Franco R, Franco J, Heuman DM. Disruption of sleep architecture in minimal hepatic encephalopathy and ghrelin secretion. Aliment Pharmacol Ther 201;34:103-105.
  • 21
    Kappus MR, Leszczyszyn DJ, Moses L, Raman S, Heuman DM, Bajaj JS. Effect of obstructive sleep apnea on the sleep architecture in cirrhosis. J Clin Sleep Med 2013;9:247-251.
  • 22
    Borbely AA. A two process model of sleep regulation. Hum Neurobiol 1982;1:195-204.
  • 23
    Skene DJ, Papagiannidou E, Hashemi E, Snelling J, Lewis DF, Fernandez M, et al. Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices. J Pineal Res 2001;31:333-342.
  • 24
    Green CB, Takahashi JS, Bass J. The meter of metabolism. Cell 2008;134:728-742.
  • 25
    Albrecht U. Timing to perfection: the biology of central and peripheral circadian clocks. Neuron 2012;74:246-260.
  • 26
    Archer SN, Robilliard DL, Skene DJ, Smits M, Williams A, Arendt J, et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 2003;26:413-415.
  • 27
    Serretti A, Benedetti F, Mandelli L, Lorenzi C, Pirovano A, Colombo C, et al. Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 2003;121:35-38.
  • 28
    Langner R, Rensing L. Circadian rhythm of oxygen consumption in rat liver suspension culture: changes of pattern. Z Naturforsch B 1972;27:1117-1118.
  • 29
    Balsalobre A, Damiola F, Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 1998;93:929-937.
  • 30
    Yamazaki S, Numano R, Abe M, Hida A, Takahashi R, Ueda M, et al. Resetting central and peripheral circadian oscillators in transgenic rats. Science 2000;288:682-685.
  • 31
    Iurisci I, Filipski E, Sallam H, Harper F, Guettier C, Maire I, et al. Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib. Chronobiol Int 2009;26:1169-1188.
  • 32
    Asher G, Schibler U. Crosstalk between components of circadian and metabolic cycles in mammals. Cell Metab 2011;13:125-137.
  • 33
    Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 2009;324:654-657.
  • 34
    Katada S, Sassone-Corsi P. The histone methyltransferase MLL1 permits the oscillation of circadian gene expression. Nat Struct Mol Biol 2010;17:1414-1421.
  • 35
    Gatfield D, Le Martelot G, Vejnar CE, Gerlach D, Schaad O, Fleury-Olela F, et al. Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev 2009;23:1313-1326.
  • 36
    Blake H, Gerard RW. Brain potentials during sleep. Am J Physiol 1937;119:692-703.
  • 37
    Werth E, Dijk DJ, Achermann P, Borbely AA. Dynamics of the sleep EEG after an early evening nap: experimental data and simulations. Am J Physiol 1996;271:R501-R510.
  • 38
    Landolt HP. Sleep homeostasis: a role for adenosine in humans? Biochem Pharmacol 2008;75:2070-2079.
  • 39
    Steindl PE, Finn B, Bendok B, Rothke S, Zee PC, Blei AT. Disruption of the diurnal rhythm of plasma melatonin in cirrhosis. Ann Intern Med 1995;123:274-277.
  • 40
    Chojnacki C, Wachowska-Kelly P, Blasiak J, Reiter RJ, Chojnacki J. Melatonin secretion and metabolism in patients with hepatic encephalopathy. J Gastroenterol Hepatol 2013, in press.
  • 41
    Steindl PE, Ferenci P, Marktl W. Impaired hepatic catabolism of melatonin in cirrhosis. Ann Intern Med 1997;127:494.
  • 42
    Iguchi H, Kato KI, Ibayashi H. Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J Clin Endocrinol Metab 1982;54:1025-1027.
  • 43
    Montagnese S, Middleton B, Mani AR, Skene DJ, Morgan MY. On the origin and the consequences of circadian abnormalities in patients with cirrhosis. Am J Gastroenterol 2010;105:1773-1781.
  • 44
    Piscaglia F, Hermida RC, Siringo S, Legnani C, Ramadori G, Bolondi L. Cirrhosis does not shift the circadian phase of plasma fibrinolysis. Am J Gastroenterol 2002;97:1512-1517.
    Direct Link:
  • 45
    Velissaris D, Karanikolas M, Kalogeropoulos A, Solomou E, Polychronopoulos P, Thomopoulos K, et al. Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy. World J Gastroenterol 2008;14:4190-4195.
  • 46
    Montagnese S, Middleton B, Mani AR, Skene DJ, Morgan MY. Changes in the 24-h plasma cortisol rhythm in patients with cirrhosis. J Hepatol 2011;54:588-90.
  • 47
    Blei AT, Zee P. Abnormalities of circadian rhythmicity in liver disease. J Hepatol 1998;29:832-835.
  • 48
    Weyerbrock A, Timmer J, Hohagen F, Berger M, Bauer J. Effects of light and chronotherapy on human circadian rhythms in delayed sleep phase syndrome: cytokines, cortisol, growth hormone, and the sleep-wake cycle. Biol Psychiatry 1996;40:794-797.
  • 49
    De Rui M, Gaiani S, Middleton B, Skene DJ, Schiff S, Gatta A, et al. Bright times for patients with cirrhosis and delayed sleep habits: a case report on the beneficial effect of light therapy. Am J Gastroenterol 2011;106:2048-2049.
  • 50
    Kurtz D, Zenglein JP, Imler M, Girardel M, Grinspan G, Peter B, et al. [Night sleep in porto-caval encephalopathy.] Electroencephalogr Clin Neurophysiol 1972;33:167-178.
  • 51
    Boy C, Meyer PT, Kircheis G, Holschbach MH, Herzog H, Elmenhorst D, et al. Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis. Eur J Nucl Med Mol Imaging 2008;35:589-597.
  • 52
    Montagnese S, Middleton B, Skene DJ, Morgan MY. Sleep-wake patterns in patients with cirrhosis: all you need to know on a single sheet. A simple sleep questionnaire for clinical use. J Hepatol 2009;51:690-695.